Go Pro
NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Price, News & Analysis

Mesa Laboratories logo
$125.29 -1.86 (-1.46%)
Closing price 04:00 PM Eastern
Extended Trading
$125.36 +0.06 (+0.05%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Mesa Laboratories Stock (NASDAQ:MLAB)

Advanced

Key Stats

Today's Range
$124.91
$129.54
50-Day Range
$91.36
$130.65
52-Week Range
$63.48
$132.70
Volume
123,941 shs
Average Volume
148,412 shs
Market Capitalization
$701.62 million
P/E Ratio
149.16
Dividend Yield
0.51%
Price Target
$110.00
Consensus Rating
Hold

Company Overview

Mesa Laboratories, Inc. develops, manufactures, and sells quality-control products and services used in healthcare, pharmaceutical, industrial, and other regulated environments. The company’s offerings are designed to help customers monitor processes, verify performance, and maintain compliance with applicable quality and safety requirements.

Mesa Laboratories’ products include biological indicators and other sterilization-assurance products used to evaluate sterilization processes in hospitals, dental practices, laboratories, and pharmaceutical manufacturing. The company also provides radiation-dosimetry products for monitoring occupational exposure, data loggers and environmental-monitoring systems for tracking conditions such as temperature and humidity, and products used in renal-care and dialysis applications.

Founded in 1982 and headquartered in Lakewood, Colorado, Mesa Laboratories serves customers in the United States and international markets through a combination of direct sales and distribution channels. Its products are used across healthcare, life sciences, pharmaceutical manufacturing, and industrial settings where reliable measurement and process validation are important.

AI Generated. May Contain Errors.

Mesa Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

MLAB MarketRank™: 

Mesa Laboratories scored higher than 26% of companies evaluated by MarketBeat, and ranked 803rd out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.

  • Downside Risk

    Mesa Laboratories has a consensus price target of $110.00, representing about 12.2% downside from its current price of $125.29.

  • Amount of Analyst Coverage

    Mesa Laboratories has only been the subject of 2 research reports in the past 90 days.

  • Read more about Mesa Laboratories' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesa Laboratories is 149.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesa Laboratories is 149.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.06.

  • Price to Book Value per Share Ratio

    Mesa Laboratories has a P/B Ratio of 3.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Mesa Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    7.98% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2.72, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 28.50%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Mesa Laboratories has a dividend yield of 0.53%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Mesa Laboratories does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Mesa Laboratories is 76.19%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Mesa Laboratories' dividend.
  • News Sentiment

    Mesa Laboratories has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Mesa Laboratories this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for MLAB on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Cluster Insider Buying

    2 insiders have purchased shares of Mesa Laboratories in the last three months. Multiple insiders buying is a strong bullish signal.

  • Insider Buying vs. Insider Selling

    In the past three months, Mesa Laboratories insiders have sold 74.00% more of their company's stock than they have bought. Specifically, they have bought $902,411.00 in company stock and sold $1,570,213.00 in company stock.

  • Percentage Held by Insiders

    2.80% of the stock of Mesa Laboratories is held by insiders.

  • Percentage Held by Institutions

    90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mesa Laboratories' insider trading history.
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLAB Stock News Headlines

A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.tc pixel
Mesa Laboratories, Inc.
See More Headlines

MLAB Stock Analysis - Frequently Asked Questions

Mesa Laboratories' stock was trading at $78.50 at the start of the year. Since then, MLAB stock has increased by 59.6% and is now trading at $125.29.

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings data on Monday, August, 10th. The medical instruments supplier reported $2.68 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $60.14 million for the quarter. Mesa Laboratories had a trailing twelve-month return on equity of 22.72% and a net margin of 1.92%.
Read the conference call transcript
.

Top institutional investors of Mesa Laboratories include Ranger Investment Management L.P. (3.11%), Diamond Hill Capital Management LLC Investment Advisor (2.78%), Wasatch Advisors LP (2.10%) and Bank of New York Mellon Corp (0.81%). Insiders that own company stock include Gary M Owens, John Sakys, John James Sullivan, Shiraz Shabanali Ladiwala, Siddhartha Kadia, Brian David Archbold, R Tony Tripeny, Mark Christopher Capone and Lyndsey Elizabeth Crennen.
View institutional ownership trends
.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/10/2026
Record date for 9/15 Dividend
8/31/2026
Ex-Dividend for 9/15 Dividend
8/31/2026
Dividend Payable
9/15/2026
Today
9/16/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:MLAB
CIK
724004
Employees
717
Year Founded
1982

Price Target and Rating

High Price Target
$110.00
Low Price Target
$110.00
Potential Upside/Downside
-12.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.84
Trailing P/E Ratio
149.16
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$6.71 million
Net Margins
1.92%
Pretax Margin
3.75%
Return on Equity
22.72%
Return on Assets
9.82%

Debt

Debt-to-Equity Ratio
0.73
Current Ratio
1.79
Quick Ratio
1.32

Sales & Book Value

Annual Sales
$249.13 million
Price / Sales
2.82
Cash Flow
$12.14 per share
Price / Cash Flow
10.32
Book Value
$33.71 per share
Price / Book
3.72

Miscellaneous

Outstanding Shares
5,600,000
Free Float
5,439,000
Market Cap
$701.62 million
Optionable
Not Optionable
Beta
0.97

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:MLAB) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners